Different molecules entirely
Steroids share a four-ring carbon skeleton. Sermorelin is a short chain of amino acids, structurally closer to a hormone signal than to a steroid, and it is degraded quickly by the body rather than persisting.
Different mechanisms
An anabolic steroid binds androgen receptors and drives an effect directly. Sermorelin binds a receptor on the pituitary and asks it to release growth hormone, which means your own feedback loops still govern the output.
Why that distinction is practical, not semantic
Because release stays within your own regulatory limits, effects tend to be gradual rather than dramatic. People expecting steroid-like changes on a peptide that works through their own pituitary will be disappointed, and that expectation gap is the real problem.
Sermorelin is a growth hormone-releasing hormone analogue: it signals the pituitary rather than supplying growth hormone.
What it is also not
It is not growth hormone itself. Injected growth hormone overrides your system; sermorelin stimulates it. Conflating those three categories, steroids, growth hormone and secretagogues, is the most common error in this conversation.
The regulatory reality
Compounded sermorelin is not FDA-approved, and long-term outcome data in healthy adults are limited. That is a fair criticism to hold, and a different criticism from calling it a steroid. See the 30-second film answers for this medication.
How sermorelin works with your own pituitary
Sermorelin is a synthetic fragment of growth hormone-releasing hormone, the signal the hypothalamus normally sends to the pituitary. It binds the GHRH receptor and prompts the pituitary to release growth hormone that your body makes itself. That is the mechanistic distinction from administering recombinant HGH, which supplies the hormone directly and overrides the signalling loop. Because sermorelin works upstream, the body’s own negative feedback remains in place, and release stays pulsatile rather than continuous. This is also why it is not an anabolic steroid: steroids act on androgen receptors, a completely separate pathway. Sermorelin is not a steroid spells that out. According to FDA records, sermorelin was previously approved as a diagnostic agent; current compounded use is not FDA-approved.
Compounded medications are not FDA-approved.
Why timing and administration matter
Growth hormone release is naturally pulsatile and largest during early deep sleep. That is the reasoning behind the common instruction to administer sermorelin at bedtime on an empty stomach, since elevated glucose and insulin blunt GH release. It is a mechanistic rationale rather than proof of a better outcome, and your clinician’s instructions govern. Preparations are typically subcutaneous, with site rotation, and reconstituted product is refrigerated per the pharmacy’s instructions. Where to inject sermorelin and refrigeration cover the handling detail. If your schedule makes bedtime dosing impractical, that is worth raising rather than improvising, because consistency generally matters more than any single ideal time.
What the evidence supports, stated plainly
Sermorelin reliably raises growth hormone and IGF-1 in studies, which is a pharmacodynamic result rather than a clinical outcome. What has not been established in adults using compounded sermorelin for wellness purposes is that those raised levels translate into specific improvements in body composition, sleep quality, recovery, or ageing. Compounded sermorelin is not FDA-approved, and FDA does not review compounded preparations for safety, effectiveness, or quality before marketing. Anyone describing guaranteed results is telling you something the evidence does not support. The reasonable framing is that the mechanism is well characterised, the downstream clinical picture is not, and a licensed clinician weighs that uncertainty against your history before deciding whether treatment is appropriate.
What happens if you stop
Because sermorelin stimulates your own pituitary rather than replacing a hormone, stopping does not create the dependency picture associated with exogenous hormone administration. Growth hormone and IGF-1 levels would be expected to return toward your untreated baseline over time, and any effects attributable to the elevated levels would likewise recede. There is no established taper requirement, but discontinuation is still a clinical conversation: your clinician may want to reassess what you were treating, what changed, and whether anything else in your history warrants follow-up. Stopping sermorelin covers the practical side. Do not stop or restart a prescription based on something you read; tell the clinician who prescribed it.
No card needed to see it. No insurance accepted or required.
Frequently asked questions
Will it show up on a drug test?
Testing policies vary by organisation and sport, and peptide secretagogues are treated differently from steroids. Check with the specific governing body rather than assuming.
Is it safer because it is not a steroid?
Different is not automatically safer. It has its own considerations, and a licensed clinician should assess whether it is appropriate for you.
Is sermorelin a steroid?
No. Sermorelin is a growth hormone-releasing hormone analogue that acts on the GHRH receptor to prompt your own pituitary. Anabolic steroids act on androgen receptors, an entirely separate pathway.
Is sermorelin FDA approved?
Sermorelin was previously approved as a diagnostic agent. Compounded sermorelin prescribed for wellness purposes is not FDA-approved, and FDA does not review compounded preparations for safety, effectiveness, or quality before marketing.
Does sermorelin work?
Sermorelin reliably raises growth hormone and IGF-1 in studies, which is a pharmacodynamic result. Whether that produces specific clinical improvements in body composition, sleep, or recovery is not established.
What happens when you stop taking sermorelin?
Because it stimulates your own pituitary rather than replacing a hormone, growth hormone and IGF-1 would be expected to return toward your untreated baseline. Discuss discontinuation with the clinician who prescribed it.
Get the real answer for your situation
A licensed clinician can tell you whether it fits you at all. Rx only.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- Peer-reviewedPrakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs 1999;12:139-157
- ReferenceCleveland Clinic: Growth hormone (somatotropin)
- FDA databaseDrugs@FDA: sermorelin acetate records
- FDA guidanceFDA: Compounding and the FD&C Act, Section 503A
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on Sermorelin
Same medication, different question.
